StockMarketLoopMaking Easy MoneySubscribe
Analysis$CGON

$CGON Won't Fall, and the Shorts Are Running Out of Time. How Does This End?

Short volume is a clue, not a confession. My read on what it does and doesn't say about CG Oncology, Inc. Common stock.

$CGON Won't Fall, and the Shorts Are Running Out of Time. How Does This End?

Listen: hear this article read aloud (about 2 min).

Somebody is still shorting CG Oncology, Inc. Common stock into this, and the FINRA data doesn't care about anyone's opinion. It counts.

$CGON sits at $83.01, $10.94 below its 20-day high of $93.95 and $23.15 above its 20-day low of $59.86.

My read: lean bullish. Buyers are close enough to force the issue, but I want volume before I call it a breakout.

The shorts have a problem

Against its own 60-session range, $CGON is 11.6% below the high of $93.95 (Nov 16) and 40.2% above the low of $59.22 (Oct 19).

$CGON closed higher in 4 of its last 9 sessions. Volume over the last five sessions averaged 2.0x the twenty sessions before them. The largest one-day move in the past twenty sessions was +17.3% on Nov 6.

52% of CGON's off-exchange volume printed as short sales (FINRA daily short volume).

The stock is already running, and the run has gone parabolic: shorts are losing, not waiting.

What I make of it: a crowded short matters only if the stock stops falling, and then covering becomes buying. Whether that starts here is the whole question.

Who is positioned for what

Off-exchange trading: NORMAL: $2.6M block at $83.00. Biggest single off-exchange print: 31,500 shares at $83.00, about $2.6M, on a downtick (seller hit). A print that size is one order being crossed away from the public book, not a crowd of small trades. Squeeze risk 15 of 100; shorts pressing 15 of 100. Across the broader market, the read is Lean bearish (bias -28).

Insiders: quiet.

On the daily chart, technical patterns include inside_bar, long_legged_doji, inside_bar in a up trend. Price is above its 20-day average of $67.37 by 23.2%.

What I make of it: the pieces mostly point the same way as the price, which is more than I can say for most setups. None of them is proof.

The bull case

  • Short squeeze setup with a measured path to $94.63

The bear case

  • Backdrop: Lean bearish (bias -28)
  • Borrow cost decides who exits first

What I think traders are overlooking

What I think traders are overlooking is how little room the thesis needs. The line that proves it wrong is close and the level it points to is not, which is the kind of imbalance I like to see.

None of that is visible in the candles.

What happens next, and when I'm out

If $CGON posts a close above the recent high on rising volume and volume expands, I think $94.63 becomes the next serious test. Under $74.71, I'm wrong.

The honest objection is that short volume is not a short position. A high ratio is routine in liquid names, and sometimes the shorts are simply right.

Clear the level on volume and I'm interested. Fail below the line and I'm out of the idea.

Kill switch

Any one of these and the thesis is over, no averaging down, no renaming it.

  • A close through $74.71.
  • Selling absorbs the buying at a key level and price loses it on volume.
  • Order flow reverses: the sweeps and blocks turn to the other side.
  • A scheduled event changes the picture before the trigger is reached.

My read

Buyers are close enough to force the issue. I want the volume before I call it anything more than a lean.

Desk record. 43 of 263 scenario targets traded before their invalidation (16%), 151 stopped out, 69 ran out of time, average outcome -0.02% per piece. Past pieces say nothing about this one.

The desk's scenario leans bullish. Bull or bear, the kill switch above is what keeps either view honest.

Sources and further reading: SEC EDGAR filings for CGON · FINRA daily short sale volume files · Nasdaq short interest: CGON · CG Oncology, Inc. Common stock investor site · CGON quote, chart and data on StockMarketLoop.

Data as of Nov 16, 12:04 PM ET: options positioning, FINRA short volume, the off-exchange trade record, the structure map, SEC filings and the ticker's headlines. Vaughn McNair (Grandmaster-Obi) and Making Easy Money may hold or trade positions in the names discussed. This is speculation and education, not financial advice.

Author disclosure: educational scenario from the Academy data desk; the author may hold or trade positions in the names discussed. This is not financial advice.
Share card
Making Easy Money

Sign up now to get access to the library of members-only issues.

Free. Confirm by email. One click to leave.

Discussion (0)

Sign in to join the discussion.